PSE & Pfizer form the Systems-based Pharmaceutics Alliance

LONDON--()--Process Systems Enterprise Ltd and Pfizer Inc., today announced that they have formed the Systems-based Pharmaceutics Alliance (SbP Alliance). The Alliance also includes a second major pharmaceutical company.

The SbP Alliance aims to develop a single model-based framework for drug substance manufacturing, drug product manufacturing, oral absorption and pharmacokinetics. The Alliance will seek to establish best practices in the application of model-based techniques which will be incorporated in validated commercial-quality computer software for the solution of industrially-important problems.

To more rapidly meet the Alliance’s objectives, the partners are further exploring opportunities to partner with additional, interested companies.

Contacts

Process Systems Enterprise Ltd
For further information please contact SbP-info@psenterprise.com
or
Kate Burness, +44-20-8563-0888
k.burness@psenterprise.com
www.psenterprise.com/news/pr140327.html

Release Summary

PSE & Pfizer announce the formation of the Systems-based Pharmaceutics Alliance (SbP Alliance).

Sharing

Contacts

Process Systems Enterprise Ltd
For further information please contact SbP-info@psenterprise.com
or
Kate Burness, +44-20-8563-0888
k.burness@psenterprise.com
www.psenterprise.com/news/pr140327.html